Having implicated the immune microenvironment as a potential causative factor promoting indolence in ATRX-deficient glioma, we sought to determine the extent to which ATRX depletion promotes increased immune cell infiltration in our in vivo models. This evidence concerns the gene ATRX and central nervous system cancer.